Nanomedicines continue to accelerate the forefront of drug delivery technologies. Inorganic mesoporous silica nanoparticles are a driving force with their unique and superlative properties. Recently, formulation researches with mesoporous silica nanoparticles have advanced many drug delivery systems, including liposome, microsphere, oro-dispersible film, 3D-printed formulation, and microneedle.
Dipy Vasa from Pfizer focuses this talk on mesoporus silica solubility-enabling technology background and examples, her teams current work, experimental setup, controlling drug release with HPMCAS and potential applications to this approach.
FREE WEBINAR: Tuning Drug Release from Mesoporus Silica Particles: Impact of HPMCAS Polymer
Dipy Vasa, PhD
Senior Scientist, Drug Product Design
Please fill out the form to access the video presentation.
Enjoy the video presentation.
2023 Global Drug Bioavailability Enhancement Summit
(May 16-17, 2023, Princeton, NJ)